These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 32213428)
1. An updated role of astragaloside IV in heart failure. Zang Y; Wan J; Zhang Z; Huang S; Liu X; Zhang W Biomed Pharmacother; 2020 Jun; 126():110012. PubMed ID: 32213428 [TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases. Tan YQ; Chen HW; Li J Drug Des Devel Ther; 2020; 14():3731-3746. PubMed ID: 32982178 [TBL] [Abstract][Full Text] [Related]
3. Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV. Xu Z; Zhou H; Zhang Y; Cheng Z; Wan M; Qin W; Li P; Feng J; Shao S; Xue W; Guo H; Liu B Biomed Pharmacother; 2023 Dec; 168():115752. PubMed ID: 37875045 [TBL] [Abstract][Full Text] [Related]
4. Research review on the pharmacological effects of astragaloside IV. Li L; Hou X; Xu R; Liu C; Tu M Fundam Clin Pharmacol; 2017 Feb; 31(1):17-36. PubMed ID: 27567103 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats. Huang C; Qiu S; Fan X; Jiao G; Zhou X; Sun M; Weng N; Gao S; Tao X; Zhang F; Chen W Biomed Pharmacother; 2021 Dec; 144():112354. PubMed ID: 34794233 [TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Luo Y; Qin Z; Hong Z; Zhang X; Ding D; Fu JH; Zhang WD; Chen J Neurosci Lett; 2004 Jun; 363(3):218-23. PubMed ID: 15182947 [TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway. Wei Y; Wu Y; Feng K; Zhao Y; Tao R; Xu H; Tang Y J Ethnopharmacol; 2020 Mar; 249():112404. PubMed ID: 31739105 [TBL] [Abstract][Full Text] [Related]
8. Research progress of astragaloside IV in treating acute kidney injury. Liu Y; Huang Y; Sun D; Ye N; Chen T; Yang M; Zhou L; Zou H Int Urol Nephrol; 2024 Aug; 56(8):2645-2650. PubMed ID: 38494585 [TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV protects against the pathological cardiac hypertrophy in mice. Liu ZH; Liu HB; Wang J Biomed Pharmacother; 2018 Jan; 97():1468-1478. PubMed ID: 29793309 [TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Zhang WD; Chen H; Zhang C; Liu RH; Li HL; Chen HZ Planta Med; 2006 Jan; 72(1):4-8. PubMed ID: 16450288 [TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV: A promising natural neuroprotective agent for neurological disorders. Yao M; Zhang L; Wang L Biomed Pharmacother; 2023 Mar; 159():114229. PubMed ID: 36652731 [TBL] [Abstract][Full Text] [Related]
12. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress. Ji C; Luo Y; Zou C; Huang L; Tian R; Lu Z BMC Pharmacol Toxicol; 2018 Sep; 19(1):53. PubMed ID: 30176914 [TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro. Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303 [TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy. Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369 [TBL] [Abstract][Full Text] [Related]
15. Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis. Ren C; Zhao X; Liu K; Wang L; Chen Q; Jiang H; Gao X; Lv X; Zhi X; Wu X; Li Y J Ethnopharmacol; 2023 Apr; 305():116128. PubMed ID: 36623754 [TBL] [Abstract][Full Text] [Related]
16. Research progress of astragaloside IV in the treatment of atopic diseases. Yu S; Peng W; Qiu F; Zhang G Biomed Pharmacother; 2022 Dec; 156():113989. PubMed ID: 36411656 [TBL] [Abstract][Full Text] [Related]
17. The experimental study of Astragalus membranaceus on meridian tropsim: the distribution study of astragaloside IV in rat tissues. Chang YX; Sun YG; Li J; Zhang QH; Guo XR; Zhang BL; Jin H; Gao XM J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():71-5. PubMed ID: 23217309 [TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV inhibits apoptotic cell death in the guinea pig cochlea exposed to impulse noise. Xiong M; He Q; Lai H; Wang J Acta Otolaryngol; 2012 May; 132(5):467-74. PubMed ID: 22217340 [TBL] [Abstract][Full Text] [Related]
19. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects]. You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134 [TBL] [Abstract][Full Text] [Related]
20. [Nuclear cardiology study on effective ingredients of Astragalus membranaceus in treating heart failure]. Luo HM; Dai RH; Li Y Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Dec; 15(12):707-9. PubMed ID: 8732134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]